Abbott acquires medical tests maker Alere for US$5.8 billion
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
ABBOTT said on Monday that it had agreed to acquire Alere for an expected US$5.8 billion to enhance its diagnostics business.
Alere, which had a market value of US$3.2 billion last Friday, makes "point of care" medical tests that can provide results in a matter of minutes. The company, based in Waltham, Massachusetts, will become a subsidiary of Abbott, which is expecting to have annual diagnostic sales of US$7 billion after the transaction closes, according to a statement released by the companies on Monday. "We want to offer our customers the best and broadest diagnostics solutions," Miles White, chairman and chief executive of Abbott, said. "Alere helps us do that."
Share with us your feedback on BT's products and services
TRENDING NOW
S-E Asia tourism takes hit from Middle East crisis, but intra-regional travel could spell hope
Higher costs, lower returns: Why are Singaporeans still betting on real estate?
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
